title: Efalizumab-induced subacute cutaneous lupus erythematosus.
authors.forename: Danette D
authors.initials: DD
authors.lastname: Bentley
authors.forename: Julia E
authors.initials: JE
authors.lastname: Graves
authors.forename: David I
authors.initials: DI
authors.lastname: Smith
authors.forename: Michael P
authors.initials: MP
authors.lastname: Heffernan
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D017676:Lichen Planus, Oral / Q000188:drug therapy; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab